Subtype
Hepatocellular Carcinoma
CI-CAN-00002853HCC · LIHCExplore in graph →
693 active trials13 approved drugs9 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002853HCC · LIHCExplore in graph →
Clinical trials
3,126 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (357)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00460681 | Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular Carcinoma | unknown | Phase 3 | 220 | Fudan UniversityOTHER | 1 | Oct 31, 2007 | clinicaltrials |
| NCT00386984 | Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma | completed | Phase 3 | 108 | University Hospital FreiburgOTHER | 1 | Oct 12, 2006 | clinicaltrials |
| NCT00355212 |
| Comparison Between Radiofrequency Versus Ethanol Injection for the Treatment of Hepatocellular Carcinoma |
| terminated |
| Phase 3 |
| 240 |
| Azienda Ospedaliera San Giovanni BattistaOTHER |
| 1 |
| Jul 25, 2006 |
| clinicaltrials |
| NCT00273247 | Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis | completed | Phase 3 | 150 | National Cancer Institute, MilanOTHER | 1 | Jan 9, 2006 | clinicaltrials |
| NCT00149565 | Phase Ⅲ Randomized Trial in Postoperative Hepatocellular Carcinoma | completed | Phase 3 | 268 | National Health Research Institutes, TaiwanOTHER | 1 | Dec 16, 2005 | clinicaltrials |
| NCT00121914 | Treatment of Hepatocellular Carcinoma: Long-Acting Somatostatin Plus Percutaneous Ethanol Instillation (PEI) Versus Long-Acting Somatostatin Alone | unknown | Phase 3 | 120 | Medical University of ViennaOTHER | 1 | Oct 18, 2005 | clinicaltrials |
| NCT00034333 | Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads Vs. IV Doxorubicin in Treating Liver Cancer | terminated | Phase 2 / Phase 3 | 240 | FeRxINDUSTRY | 8 | Jun 24, 2005 | clinicaltrials |
| NCT00057382 | T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients | terminated | Phase 2 / Phase 3 | 750 | TularikINDUSTRY | 11 | Jun 24, 2005 | clinicaltrials |
Data updated 23 days agoSource updated Oct 31, 2007source: clinicaltrials